Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1997 Nov 1;157(9):1235–1242.

Management of women at increased risk for breast cancer: preliminary results from a new program

P L Chart 1, E Franssen 1
PMCID: PMC1228353  PMID: 9361645

Abstract

OBJECTIVE: To examine the characteristics of malignant tumours that develop in women undergoing surveillance for increased risk for breast cancer and to identify presentation patterns in order to determine the respective roles of mammography, clinical breast examination (CBE) and breast self-examination (BSE). SETTING: Breast Diagnostic Clinic and Familial Breast Cancer Clinic at Toronto-Sunnybrook Regional Cancer Centre. PARTICIPANTS: A total of 1044 women evaluated for breast cancer risk from Oct. 1, 1990, to Dec. 31, 1996, of whom 381 were categorized as being at high risk, 204 as being at moderate risk, 401 as being at slightly increased risk and 58 as being at no appreciably increased risk. PROGRAM COMPONENTS: Comprehensive review and discussion of risk factors, clinical assessment, surveillance recommendations that include mammography, CBE and BSE, genetics consultation (Familial Breast Cancer Clinic) and psychosocial support. Data are captured prospectively, updated at each visit and audited every 3 to 6 months. PROGRAM OUTCOMES: During the study period breast cancer was diagnosed in 24 patients, 12 in the high-risk group, 4 in the moderate-risk group and 8 in the group at slightly increased risk. The mean age at diagnosis was 47 (range 32 to 82) years. Ten cases of cancer were diagnosed during surveillance (incident cancer), 5 in women under age 50. The mean length of time from initial assessment to diagnosis was 28.6 (range 12 to 51) months. Of the 24 women, 17 reported a family history of breast cancer. The mean age at diagnosis in this cohort was 45.5 years, and the diagnosis was made under age 50 in 10 patients (59%). The mean earliest age at which breast cancer was diagnosed in a family member was 42.5 years. CONCLUSIONS: These preliminary results suggest that surveillance of women at increased risk for breast cancer may be useful in detecting disease at an early stage. The regular performance of mammography, CBE and BSE appears necessary to achieve these results.

Full Text

The Full Text of this article is available as a PDF (195.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baines C. J., Miller A. B., Bassett A. A. Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer. 1989 May 1;63(9):1816–1822. doi: 10.1002/1097-0142(19900501)63:9<1816::aid-cncr2820630926>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  2. Becher H., Chang-Claude J. Estimating disease risks for individuals with a given family history in different populations with an application to breast cancer. Genet Epidemiol. 1996;13(3):229–242. doi: 10.1002/(SICI)1098-2272(1996)13:3<229::AID-GEPI1>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  3. Biesecker B. B., Boehnke M., Calzone K., Markel D. S., Garber J. E., Collins F. S., Weber B. L. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993 Apr 21;269(15):1970–1974. [PubMed] [Google Scholar]
  4. Botkin J. R., Croyle R. T., Smith K. R., Baty B. J., Lerman C., Goldgar D. E., Ward J. M., Flick B. J., Nash J. E. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst. 1996 Jul 3;88(13):872–882. doi: 10.1093/jnci/88.13.872. [DOI] [PubMed] [Google Scholar]
  5. Claus E. B., Risch N., Thompson W. D. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer. 1994 Feb 1;73(3):643–651. doi: 10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  6. Cohen M. I., Mintzer R. A., Matthies H. J., Bernstein J. R. Mammography in women less than 40 years of age. Surg Gynecol Obstet. 1985 Mar;160(3):220–222. [PubMed] [Google Scholar]
  7. Dershaw D. D., Yahalom J., Petrek J. A. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation. Radiology. 1992 Aug;184(2):421–423. doi: 10.1148/radiology.184.2.1320281. [DOI] [PubMed] [Google Scholar]
  8. Eastman P. NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst. 1997 Apr 16;89(8):538–539. doi: 10.1093/jnci/89.8.538. [DOI] [PubMed] [Google Scholar]
  9. Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 Mar 19;343(8899):692–695. doi: 10.1016/s0140-6736(94)91578-4. [DOI] [PubMed] [Google Scholar]
  10. Gail M. H., Brinton L. A., Byar D. P., Corle D. K., Green S. B., Schairer C., Mulvihill J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989 Dec 20;81(24):1879–1886. doi: 10.1093/jnci/81.24.1879. [DOI] [PubMed] [Google Scholar]
  11. Gastrin G., Miller A. B., To T., Aronson K. J., Wall C., Hakama M., Louhivuori K., Pukkala E. Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer. 1994 Apr 15;73(8):2168–2174. doi: 10.1002/1097-0142(19940415)73:8<2168::aid-cncr2820730822>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  12. Haagensen C. D., Lane N., Lattes R., Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978 Aug;42(2):737–769. doi: 10.1002/1097-0142(197808)42:2<737::aid-cncr2820420247>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  13. Hoskins K. F., Stopfer J. E., Calzone K. A., Merajver S. D., Rebbeck T. R., Garber J. E., Weber B. L. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15;273(7):577–585. [PubMed] [Google Scholar]
  14. Houlston R. S., Lemoine L., McCarter E., Harrington S., MacDermot K., Hinton J., Berger L., Slack J. Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic. J Med Genet. 1992 Oct;29(10):691–694. doi: 10.1136/jmg.29.10.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McGuigan K. A., Ganz P. A., Breant C. Agreement between breast cancer risk estimation methods. J Natl Cancer Inst. 1996 Sep 18;88(18):1315–1317. doi: 10.1093/jnci/88.18.1315. [DOI] [PubMed] [Google Scholar]
  16. Meyer J. E., Kopans D. B., Oot R. Breast cancer visualized by mammography in patients under 35. Radiology. 1983 Apr;147(1):93–94. doi: 10.1148/radiology.147.1.6828769. [DOI] [PubMed] [Google Scholar]
  17. Miller A. B., Baines C. J., To T., Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ. 1992 Nov 15;147(10):1459–1476. [PMC free article] [PubMed] [Google Scholar]
  18. Miller A. B., Baines C. J., To T., Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ. 1992 Nov 15;147(10):1477–1488. [PMC free article] [PubMed] [Google Scholar]
  19. Morrow M. Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat. 1994;31(1):53–60. doi: 10.1007/BF00689676. [DOI] [PubMed] [Google Scholar]
  20. Nelson N. J. The mammography consensus jury speaks out. J Natl Cancer Inst. 1997 Mar 5;89(5):344–347. doi: 10.1093/jnci/89.5.344. [DOI] [PubMed] [Google Scholar]
  21. Schechter M. T., Miller A. B., Baines C. J., Howe G. R. Selection of women at high risk of breast cancer for initial screening. J Chronic Dis. 1986;39(4):253–260. doi: 10.1016/0021-9681(86)90047-0. [DOI] [PubMed] [Google Scholar]
  22. Smart C. R., Hendrick R. E., Rutledge J. H., 3rd, Smith R. A. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials. Cancer. 1995 Apr 1;75(7):1619–1626. doi: 10.1002/1097-0142(19950401)75:7<1619::aid-cncr2820750711>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  23. Tabár L., Fagerberg G., Day N. E., Duffy S. W., Kitchin R. M. Breast cancer treatment and natural history: new insights from results of screening. Lancet. 1992 Feb 15;339(8790):412–414. doi: 10.1016/0140-6736(92)90090-p. [DOI] [PubMed] [Google Scholar]
  24. Weber B. L. Susceptibility genes for breast cancer. N Engl J Med. 1994 Dec 1;331(22):1523–1524. doi: 10.1056/NEJM199412013312214. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES